USANA Health Sciences, Inc. (USNA) Fair Value 2026

USNA · Packaged Foods ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.5 /10

32 fundamental signals · 11 models active

Value Trap Risk

WARN (45/100)

Quick Summary — As of 2026-08-28, USANA Health Sciences, Inc. (USNA) trades at $14.04, versus a $30.48 median fair value across its 11 active models — 117.1% above the current price. QOC: 7.5/10. Value Trap Risk: 45/100 (WARN). 11/13 models active. Within that set, the Bayesian DCF component alone returns $13.55.

Key Facts

Ticker
USNA
Price
$14.04
Quality Score
7.5/10
Value Trap Risk
45/100
Models Active
11/13
Last Updated
Strength: First Chicago suggests +450.0% upside with 62% confidence
Risk: Value Trap score of 45 suggests caution despite apparent undervaluation

Is USANA Health Sciences, Inc. (USNA) Undervalued or Overvalued in 2026?

According to CirclFi’s 11-model valuation engine, USANA Health Sciences, Inc. (USNA) appears undervalued as of : the median of 11 independent fair value estimates is $30.48, 117.1% above the current price of $14.04. Estimates range from $1.26 to $77.22. USNA scores 7.5/10 on fundamental quality and 45/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. USNA’s +117.1% gap is wider than that market norm, and the Packaged Foods sector median is -16.7%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy USANA Health Sciences, Inc. Stock in 2026? →

What Fair Value Does Each Model Give USNA?

11 Intrinsic Value Models vs. Current Price ($14.04)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
$13.55 -3.5%
Intrinsic · High Conviction
$31.67 +125.6%
Ensemble · Low Conviction
$26.80 +90.9%
Scenario · High Conviction
$77.22 +450.0%
Unlock the Full Matrix

Access 7 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 11 Models →

Cancel anytime · No contracts · Instant access

What Is USNA's Fair Value Range?

Spread across 11 independent models · $1.26 to $77.22

CirclFi's 11 active models place USANA Health Sciences, Inc. (USNA) between $1.26 and $77.22 per share, a spread of 249% of the median. The median of that range — $30.48 — is the fair value CirclFi publishes for USNA, against a current price of $14.04.

Low · ML-RIVHigh · First Chicago
$1.26median $30.48$77.22
Where the range comes from
Most bearish modelML Residual Income$1.26
Most bullish modelFirst Chicago$77.22
Model agreement8 bullish · 2 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for USNA. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on USNA, not a CirclFi price target. How each model works →

What Is USANA Health Sciences, Inc. (USNA) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, USANA Health Sciences, Inc.'s intrinsic value is estimated at $30.48, suggesting a +117.1% median upside from the current price of $14.04. While 8 models see room for appreciation, model agreement is not unanimous as 2 models flag potential overvaluation. Model dispersion is worth noting: First Chicago targets $77.22 (+450.0%), versus ML-RIV at $1.26 (-91.0%). This +541.0% range highlights the importance of multi-model analysis rather than relying on any single methodology. Among models with highest confidence, Bayesian DCF, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About USNA?

11 of 13 models are currently active for USNA. Of these, 8 models suggest upside while 3 models suggest overvaluation. Taken together, their median fair value for USNA is $30.48 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $13.55 on its own, implying -3.5% downside from the current price. See which stocks rank higher →

How Does USNA Rank in Packaged Foods?

Among 84 Packaged Foods stocks, USNA ranks #25 by Quality of Company score. CirclFi's QOC score of 7.5/10 evaluates 32 fundamental signals. A score of 7.5 indicates above-average quality.

See all Most Undervalued Packaged Foods Stocks →

Within the Packaged Foods space, USANA Health Sciences, Inc. competes in an environment where same-store sales growth (comps) often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is USNA a Value Trap?

CirclFi's Value Trap algorithm assigns USNA a score of 45/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

11 of 13 models are active for USANA Health Sciences, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, USANA Health Sciences, Inc. is rated at 7.5/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.

The gap between the most bullish and bearish model spans +541.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every USNA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across USNA's 11 active models, average confidence is 51%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy USANA Health Sciences, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Packaged Foods Stocks Should You Also Analyze?

11 related Packaged Foods stocks with 13-model coverage

Read investment analysis: MICC · DAR · JBS · INBP · LW · HLF · HAIN · STCB · MAMA · PPC · JJSF

Which Other Stocks Have a Similar Quality Score to USNA?

7 companies across all industries closest to USNA’s Quality of Company score of 7.5/10.

Read investment analysis: CON · PPIH · HAPN · IHS · LOAN · AOMR · NVDA

Where Does USNA Sit in CirclFi's Packaged Foods Rankings?

USNA is ranked against every other Packaged Foods stock CirclFi covers in each of these screens.

See all Packaged Foods stocks ranked →

What Else Do Investors Ask About USANA Health Sciences, Inc.’s Valuation?

What is USANA Health Sciences, Inc.'s intrinsic value in 2026?

CirclFi puts USANA Health Sciences, Inc. (USNA)'s intrinsic value at $30.48 — the median of 11 independent model estimates as of 2026-08-28, ranging from $1.26 to $77.22. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $13.55 on its own. The Quality of Company score is 7.5/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is USNA overvalued or undervalued right now?

At $14.04, 8 of 11 active models suggest USNA may be undervalued, while 3 indicate potential overvaluation. The median of all 11 fair value estimates is $30.48, 117.1% above the current price of $14.04 — a consensus view that USNA is undervalued. The assessment depends on which methodology best fits USANA Health Sciences, Inc.'s business model in Packaged Foods.

What does a Quality of Company score of 7.5 mean for USNA?

USANA Health Sciences, Inc.'s QOC of 7.5/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on USNA?

CirclFi analyzes USNA with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 11 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on USNA?

Of the 11 models currently active on USNA, First Chicago is the most bullish at $77.22 per share, and ML Residual Income is the most bearish at $1.26. CirclFi's published fair value for USNA is the median of that range, $30.48, not either extreme. The gap between the two ends equals 249% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is USNA a value trap in 2026?

USANA Health Sciences, Inc.'s Value Trap score is 45/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries.

Cite this analysis — “According to CirclFi’s 11-model valuation engine, USANA Health Sciences, Inc. (USNA) has a median fair value of $30.48 — 117.1% above the current price of $14.04 — as of 2026-08-28.” Source: circlfi.com/stock/USNA/ · Methodology
Primary sources for this USNA valuation
  • Financial statements: USANA Health Sciences, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0000896264) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for USNA as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 11 mathematical frameworks give you clarity on USNA.

Unlock All 11 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

7 models hidden for USNA Unlock All 11 — $39/mo